HLA-DRB1*01 predicts treatment outcome in juvenile idiopathic arthritis: A retrospective-prospective cohort study. [PDF]
Čengić A+8 more
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
Analysis of the treatment outcome of duodenal varices: A retrospective case series of 15 patients from a single institution. [PDF]
Mitamura Y+23 more
europepmc +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy+9 more
wiley +1 more source
The Impact of Negative Emotions on the Treatment Outcome of Percutaneous Balloon Compression for Idiopathic Trigeminal Neuralgia Patients: A Longitudinal Study. [PDF]
Jiang C+4 more
europepmc +1 more source
A Case Report on the Management of Peri-Prosthetic Fracture in a Post-TKA Patient with Rheumatoid Arthritis: Surgical Strategy and Treatment Outcome. [PDF]
Rosario PMM, Ra REV.
europepmc +1 more source
The effect of GM-CSF and predictors of treatment outcome in pediatric septic shock patients. [PDF]
Yu ZH+9 more
europepmc +1 more source
Risk factors associated with morbidity and unfavorable treatment outcome in drug-resistant pulmonary tuberculosis: a case-control study. [PDF]
Li C, Liang S, Wang X, Lui S, Wang C.
europepmc +1 more source
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. [PDF]
Yamamoto N+21 more
europepmc +1 more source